Rapid Update 2 – December 2020 Type 2 Diabetes: Ertugliflozin does not show superiority versus placebo in key cardiovascular and renal outcomes

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.

Rapid Update 2 – November 2020: Gastrointestinal: proton pump inhibitors and risk of type 2 diabetes

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.

Rapid Update 1 – August 2020: Diabetes: Uptake of biosimilar insulin glargine in primary care

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.

Rapid Update 1 – February 2020: Type 2 diabetes: cohort study reports early weight loss is associated with longer-term remission

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.

Rapid Update 3 – January 2020: Cardiovascular (CV): Hygia study finds taking antihypertensive medicines at bedtime reduces CV risks

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.

Rapid Update 2 – January 2020: Cardiovascular disease: RCT finds dapagliflozin reduces hospitalisation and death in people with heart failure, including those without diabetes.

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.

Rapid Update 1 – December 2019: Type 2 diabetes: disparities in monitoring, treatment and glycaemic control across patient groups

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.

Rapid Update 3 – October 2019: Type 2 diabetes: more evidence on self monitoring of blood glucose (SMBG)?

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.

Rapid Update 2 – July 2019: Type 2 diabetes: dulaglutide and cardiovascular outcomes

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.

Rapid Update 3 – June 2019: Diabetes: Type 2 diabetes: New findings on renal outcomes with canagliflozin

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.